KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Account Payables (2016 - 2025)

Amgen (AMGN) has 17 years of Change in Account Payables data on record, last reported at -$484.0 million in Q4 2025.

  • For Q4 2025, Change in Account Payables fell 108.62% year-over-year to -$484.0 million; the TTM value through Dec 2025 reached $428.0 million, up 37.18%, while the annual FY2025 figure was $428.0 million, 37.18% up from the prior year.
  • Change in Account Payables reached -$484.0 million in Q4 2025 per AMGN's latest filing, down from -$174.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $643.0 million in Q2 2024 and bottomed at -$484.0 million in Q4 2025.
  • Average Change in Account Payables over 5 years is $21.2 million, with a median of -$74.0 million recorded in 2021.
  • Peak YoY movement for Change in Account Payables: tumbled 842.86% in 2021, then surged 2060.87% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $191.0 million in 2021, then surged by 54.97% to $296.0 million in 2022, then tumbled by 163.18% to -$187.0 million in 2023, then fell by 24.06% to -$232.0 million in 2024, then plummeted by 108.62% to -$484.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$484.0 million in Q4 2025, -$174.0 million in Q3 2025, and $589.0 million in Q2 2025.